Physician profile
Mark E Blaker
NPI 1063406171
$1,612.09
in general payments reported to CMS, 2019-2025
22 companies · $55.86 in 2025
The $55.86 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $383 · 2021: $352 · 2022: $16.76 · 2023: $28.34 · 2024: $87.31 · 2025: $55.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $264.37 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.63 | 2019-2025 | Jardiance |
| Pfizer INC. | $163.63 | 2019-2021 | |
| Amgen INC. | $154.00 | 2019-2021 | |
| Abiomed | $127.81 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $98.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $89.13 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $87.01 | 2019-2021 | |
| Vifor Pharma, INC. | $59.78 | 2021 | |
| Amarin Pharma, INC. | $50.71 | 2019 | |
| Medtronic, INC. | $49.77 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.55 | 2019 | |
| Astellas Pharma US INC | $36.07 | 2019-2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $28.34 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $27.78 | 2021-2025 | Verquvo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $25.60 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $25.31 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $19.48 | 2024 | Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $19.39 | 2024 | Arcalyst |
| Biotronik INC. | $16.35 | 2020 | |
| Lantheus Medical Imaging, INC. | $13.54 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Blaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.